2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Bile Duct Cancer
Bile duct cancer, medically termed cholangiocarcinoma, presents a formidable challenge in the realm of oncology. Though relatively uncommon, its aggressive nature demands intensive research efforts. Recent strides in cancer exploration have unveiled the intricate molecular pathways underpinning this malignancy. This newfound understanding has paved the way for targeted therapies tailored to specific genetic aberrations. Moreover, innovative immunotherapeutic interventions hold promise in bolstering the body's immune response against cancerous cells. Concurrently, endeavors to refine early detection techniques and customize treatment regimens are underway, offering a glimpse of optimism for patients grappling with this formidable adversary. The ongoing pursuit of knowledge and innovation in bile duct cancer research is pivotal, holding the potential to transform prognoses and enhance the lives of those affected by this insidious disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China